CHEBI:76018 - riociguat

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name riociguat
ChEBI ID CHEBI:76018
Definition A carbamate ester that is the methyl ester of {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamic acid. It is used for treatment of chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
more structures >>
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C20H19FN8O2
Net Charge 0
Average Mass 422.41570
Monoisotopic Mass 422.16150
InChI InChI=1S/C20H19FN8O2/c1-28(20(30)31-2)15-16(22)25-18(26-17(15)23)14-12-7-5-9-24-19(12)29(27-14)10-11-6-3-4-8-13(11)21/h3-9H,10H2,1-2H3,(H4,22,23,25,26)
InChIKey WXXSNCNJFUAIDG-UHFFFAOYSA-N
SMILES COC(=O)N(C)c1c(N)nc(nc1N)-c1nn(Cc2ccccc2F)c2ncccc12
Roles Classification
Chemical Role(s): Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
Biological Role(s): soluble guanylate cyclase activator
Any compound that binds to and activates soluble guanylate cyclase (EC 4.6.1.2).
Application(s): antihypertensive agent
Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing riociguat (CHEBI:76018) has role antihypertensive agent (CHEBI:35674)
riociguat (CHEBI:76018) has role soluble guanylate cyclase activator (CHEBI:76022)
riociguat (CHEBI:76018) is a aminopyrimidine (CHEBI:38338)
riociguat (CHEBI:76018) is a carbamate ester (CHEBI:23003)
riociguat (CHEBI:76018) is a organofluorine compound (CHEBI:37143)
riociguat (CHEBI:76018) is a pyrazolopyridine (CHEBI:46699)
IUPAC Name
methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate
INNs Sources
riociguat KEGG DRUG
riociguat WHO MedNet
riociguat WHO MedNet
riociguatum WHO MedNet
Synonyms Sources
BAY 63-2521 ChemIDplus
Methyl N-(4,6-diamino-2-{1-((2-fluorophenyl)methyl)-1H-pyrazolo(3,4-b)pyridin-3-yl}pyrimidin-5-yl)-N-methylcarbamate ChemIDplus
Brand Name Source
Adempas ChemIDplus
Manual Xrefs Databases
4807 DrugCentral
D09572 KEGG DRUG
Riociguat Wikipedia
US2009286781 Patent
WO2007009607 Patent
WO2011147810 Patent
View more database links
Registry Numbers Types Sources
12581953 Reaxys Registry Number Reaxys
625115-55-1 CAS Registry Number KEGG DRUG
625115-55-1 CAS Registry Number ChemIDplus
Citations Waiting for Citations Types Sources
19129292 PubMed citation Europe PMC
20424448 PubMed citation Europe PMC
20801938 PubMed citation Europe PMC
20956169 PubMed citation Europe PMC
21391889 PubMed citation Europe PMC
21789188 PubMed citation Europe PMC
22719060 PubMed citation Europe PMC
22900035 PubMed citation Europe PMC
22912874 PubMed citation Europe PMC
22936711 PubMed citation Europe PMC
23204120 PubMed citation Europe PMC
23397304 PubMed citation Europe PMC
23775260 PubMed citation Europe PMC
23883377 PubMed citation Europe PMC
23883378 PubMed citation Europe PMC
23883383 PubMed citation Europe PMC
23939482 PubMed citation Europe PMC
23963798 PubMed citation Europe PMC
23978639 PubMed citation Europe PMC
23997048 PubMed citation Europe PMC
23997053 PubMed citation Europe PMC
24015306 PubMed citation Europe PMC
24092345 PubMed citation Europe PMC
PMC3363218 PubMed Central citation Europe PMC
Last Modified
22 February 2017